But there's a fourth "bug" the public should be aware of: respiratory syncytial virus. RSV causes cold-like symptoms and affects the breathing passages and lungs. Wastewater levels of RSV are ...
Pfizer and GSK vaccines will now be required to carry warnings that they may be tied to an increased risk of a rare neurological side effect. © 2024 Fortune Media IP ...
COVID-19 and flu activity is increasing in most parts of the country and RSV activity remains very high, especially in young children. Respiratory illness activity in Florida is very high ...
It’s cold and flu season. And in Pennsylvania, it’s now RSV season. The respiratory illness — one that targets your airways — is the leading cause of severe respiratory infections in ...
Winter is usually accompanied by an uptick in respiratory illnesses, such as Covid-19 and RSV, and 2025 is no exception. For RSV in particular, nearly two dozen states are currently reporting high ...
RSV activity is moderate but decreasing, and COVID-19 activity continues to be low, according to the agency's latest virus report. And it may get worse soon. The United States’ highest month for ...
It's flu season. And COVID season. And RSV season. The Centers for Disease Control and Prevention (CDC) reported that as of last week, "the amount of acute respiratory illness causing people to ...
The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning about the risk of developing Guillain-Barré syndrome (GBS), a rare ...
Cases of RSV across the country are considered "very high," as rates of other acute respiratory illnesses are also high, the CDC reported Monday. Here's what to know about RSV. Iowa currently is ...
Both Lehigh Valley and St. Luke’s University health networks report increased hospitalizations related to influenza and respiratory syncytial virus, two of the most common respiratory infections ...
FDA adds warning label to RSV vaccines Abrysvo and Arexvy about the risk for Guillain-Barré syndrome
Arexvy has been approved for the prevention of lower respiratory tract disease caused by RSV in all individuals 60 years of age and older and for those aged 50 to 59 years at increased risk.
The CDC also mentioned respiratory syncytial virus (RSV), which is a virus that causes cold-like symptoms but also impacts breathing passages and the lungs. RSV has been trending upwards since ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback